Search research articles
Contact Us
Filters
Showing results (181-190 of 281) with videos related to
Page
of 29
Sort By:
Oncotarget
|
October 30, 2016
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Marieke I G Raaijmakers, Daniel S Widmer, Apurva Narechania, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes
Cadri Knoch, Veronika Baghin, Patrick Turko, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Stefan Diem, Mirjam Fässler, David Bomze, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor
R Doyonnas, J Yi-Hsin Chan, L H Butler, et al.
Cancer Immunology Research
|
July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors
Jessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Science Advances
|
August 14, 2018
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread
Qiaoli Ma, Lothar C Dieterich, Kristian Ikenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2020
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
Lucas Basler, Hubert S Gabryś, Sabrina A Hogan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Marie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.
BMC Medical Informatics and Decision Making
|
October 31, 2018
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics
Franziska Singer, Anja Irmisch, Nora C Toussaint, et al.
Cancer Research
|
September 7, 2018
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth
Christine Pich, Patrick Meylan, Beatris Mastelic-Gavillet, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 281) with videos related to
Sort By:
Page
of 29
Oncotarget
|
October 30, 2016
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Marieke I G Raaijmakers, Daniel S Widmer, Apurva Narechania, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes
Cadri Knoch, Veronika Baghin, Patrick Turko, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Stefan Diem, Mirjam Fässler, David Bomze, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor
R Doyonnas, J Yi-Hsin Chan, L H Butler, et al.
Cancer Immunology Research
|
July 15, 2020
Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors
Jessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
Science Advances
|
August 14, 2018
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread
Qiaoli Ma, Lothar C Dieterich, Kristian Ikenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2020
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
Lucas Basler, Hubert S Gabryś, Sabrina A Hogan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Marie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.
BMC Medical Informatics and Decision Making
|
October 31, 2018
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics
Franziska Singer, Anja Irmisch, Nora C Toussaint, et al.
Cancer Research
|
September 7, 2018
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth
Christine Pich, Patrick Meylan, Beatris Mastelic-Gavillet, et al.
Page
of 29